Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Moderna's $500M pact with Nanexa to improve injectables delivery
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to four injectable therapies.
James Waldron
Dec 11, 2025 7:35am
Zealand pens $2.5B cardiometabolic collab with Chinese biotech
Dec 11, 2025 5:45am
Formation Bio makes $605M play for Lynk's TYK2 inhibitor
Dec 10, 2025 10:27am
Pfizer signs $1.9B pact for Fosun unit's GLP-1 drug
Dec 9, 2025 8:00am
GSK initiates breakup with Ideaya, hands back 2 programs
Dec 9, 2025 7:15am
Novartis pens $1.7B atopic disease pact with British biotech
Dec 9, 2025 3:57am